1. Spinal anesthesia in neonates and infants - a single-center experience of 505 cases
- Author
-
Evelina Tarabikin, Elia Peled, Iulia Metzner, Eliahu Simhi, Elena Tzeitlin, Rachel Efrat, Ludmyla Kachko, and Jacob Katz
- Subjects
Bradycardia ,Male ,medicine.medical_specialty ,Side effect ,Apnea ,Midazolam ,Gestational Age ,Infant, Premature, Diseases ,Single Center ,Anesthesia, Spinal ,Postoperative Complications ,Medicine ,Humans ,Hypnotics and Sedatives ,Anesthetics, Local ,Intraoperative Complications ,Retrospective Studies ,Bupivacaine ,business.industry ,Body Weight ,Infant, Newborn ,Gestational age ,Infant ,Retrospective cohort study ,Surgery ,Anesthesiology and Pain Medicine ,Anesthesia ,Pediatrics, Perinatology and Child Health ,Orthopedic surgery ,Female ,medicine.symptom ,Hypotension ,business ,Infant, Premature ,medicine.drug - Abstract
Summary Background: Our aim was to assess the safety and efficacy of spinal anesthesia (SA) in newborns and infants undergoing surgery appropriate for this technique. Methods: The files of 505 patients who underwent surgery under spinal anesthesia since 1998 at a major tertiary hospital in Israel were analyzed retrospectively. SA was performed with bupivacaine 5 mg·ml−1 by attending pediatric anesthesiologists or an anesthesia resident. Demographic data, prematurity history, comorbidities, technical data, cardiovascular stability, complications and supplementary drugs were documented. The surgeon assessed the quality of anesthesia at the end of surgery. Results: Appropriate SA was achieved in 95.3% of cases; in 69.9% at the first attempt. The mean number of attempts per patient was 1.41 and mean dose of bupivacaine was 0.66 ± 0.16 mg·kg−1. Intravenous sedation, usually with midazolam (dose 0.1–0.2 mg·kg−1) was required in 28.1% of children because of crying/restlessness. Intraoperative conversion to general anesthesia was necessary in five patients (1.04%). The main side effect was bradycardia (
- Published
- 2007